Inventor · disambiguated record
Lijun Sun
Also filed as: SUN LIJUN
141 granted patents·59 pending applications·2,108 citations·filing 1996–2024
99Inventor score
Files withSYNTA PHARMACEUTICALS CORP86IMMUNESENSOR THERAPEUTICS INC18SUN LIJUN14CHEN SHOUJUN10BETH ISRAEL DEACONESS MEDICAL CT INC9
Top patents by PatentIndex Score
200 records- 0198US7435843B2Synthesis of taxol enhancersSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Oct 14, 2008·36 cites·4 claims
- 0298US7368473B2Paclitaxel enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted May 6, 2008·40 cites·23 claims
- 0398US6171614B1Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereofUNIV EMORY·Filed 2000·Granted Jan 9, 2001·139 cites·20 claims
- 0497US10426184B1Seaweed meal and method of making the sameNUTRIOMIX INC·Filed 2018·Granted Oct 1, 2019·8 cites·28 claims
- 0597US8053456B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Nov 8, 2011·58 cites·12 claims
- 0697US7074952B2Synthesis of taxol enhancersSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Jul 11, 2006·49 cites·25 claims
- 0797US7001923B2Taxol enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Feb 21, 2006·52 cites·24 claims
- 0897US6825235B2Synthesis of taxol enhancersSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Nov 30, 2004·60 cites·60 claims
- 0997US6762204B2Taxol enhancer compoundsSYNTA PHARMACEUTICALS INC·Filed 2002·Granted Jul 13, 2004·74 cites·125 claims
- 1096US8415377B2Triazole compounds that modulate HSP90 activitySUN LIJUN·Filed 2011·Granted Apr 9, 2013·40 cites·19 claims
- 1196US8318790B2Triazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2007·Granted Nov 27, 2012·49 cites·68 claims
- 1296US7750042B2Paclitaxel enhancer compoundSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Jul 6, 2010·14 cites·32 claims
- 1396US7615552B2Fused heterocyclic compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Nov 10, 2009·87 cites·46 claims
- 1496US7345094B2Paclitaxel enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Mar 18, 2008·40 cites·31 claims
- 1596US7037940B2Taxol enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted May 2, 2006·55 cites·24 claims
- 1696US6924312B2Taxol enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Aug 2, 2005·58 cites·3 claims
- 1796US6800660B2Taxol enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Oct 5, 2004·71 cites·117 claims
- 1895US8835464B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Sep 16, 2014·32 cites·17 claims
- 1995US8299107B2Triazole compounds that modulate HSP90 activityCHIMMANAMADA DINESH U·Filed 2008·Granted Oct 30, 2012·49 cites·38 claims
- 2095US7645904B2Purification of bis(thiohydrazide amides)SYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Jan 12, 2010·18 cites·29 claims
- 2195US7385084B2Bis(thio-hydrazide amide) salts for treatment of cancersSYNTA PHARMACEUTICAL CORP·Filed 2005·Granted Jun 10, 2008·45 cites·34 claims
- 2294US8742133B2Triazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2008·Granted Jun 3, 2014·36 cites·15 claims
- 2394US7795313B2Bis(thio-hydrazide amide) salts for treatment of cancersSYNTA PHARMACEUTICALS CORP·Filed 2009·Granted Sep 14, 2010·22 cites·18 claims
- 2494US7709518B2Compounds for inflammation and immune-related usesSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted May 4, 2010·33 cites·19 claims
- 2594US7579503B2BIS (thio-hydrazide amide) salts for treatment of cancersSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Aug 25, 2009·23 cites·15 claims
- 2694US6858606B2Pyrimidine compoundsSYNTA PHARMACEUTICAL CORP·Filed 2002·Granted Feb 22, 2005·55 cites·30 claims
- 2794US6660733B22,4,6-trisubstituted-pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·69 cites·25 claims
- 2893US11033635B2Antibody-STING agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2020·Granted Jun 15, 2021·3 cites·28 claims
- 2993US7919487B2Heteroaryl compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Apr 5, 2011·34 cites·15 claims
- 3093US7863270B2IL-12 modulatory compoundsSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Jan 4, 2011·24 cites·4 claims
- 3193US7671092B2Paclitaxel enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Mar 2, 2010·16 cites·5 claims
- 3293US7067514B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Jun 27, 2006·42 cites·46 claims
- 3393US6743919B22-aroylimidazole compounds for treating cancerSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Jun 1, 2004·30 cites·66 claims
- 3493US6693097B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2001·Granted Feb 17, 2004·60 cites·39 claims
- 3592US11873291B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Jan 16, 2024·3 cites·52 claims
- 3692US7923557B2Process for preparing trisubstituted pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Apr 12, 2011·24 cites·8 claims
- 3792US7652168B2Synthesis of taxol enhancersSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Jan 26, 2010·13 cites·8 claims
- 3891US10633411B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2019·Granted Apr 28, 2020·3 cites·30 claims
- 3991US8093425B2Compounds for treating proliferative disordersKOYA KEIZO·Filed 2008·Granted Jan 10, 2012·8 cites·18 claims
- 4091US6958332B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Oct 25, 2005·39 cites·32 claims
- 4191US6071532ASynthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereofUNIV EMORY·Filed 1996·Granted Jun 6, 2000·101 cites·16 claims
- 4290US10947206B2cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2018·Granted Mar 16, 2021·3 cites·46 claims
- 4390US7781462B2Compounds for the treatment of proliferative disordersSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Aug 24, 2010·5 cites·23 claims
- 4490US7745436B2Disalt inhibitors of IL-12 productionSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Jun 29, 2010·15 cites·6 claims
- 4590US7470685B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Dec 30, 2008·11 cites·33 claims
- 4690US6680315B2Triazine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2001·Granted Jan 20, 2004·34 cites·46 claims
- 4789US11096974B1Superabsorbent materials and methods of making the sameNUTRIOMIX INC·Filed 2021·Granted Aug 24, 2021·1 cites·23 claims
- 4889US8748424B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2012·Granted Jun 10, 2014·12 cites·3 claims
- 4989US7470681B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Dec 30, 2008·12 cites·25 claims
- 5089US7122665B2Heterocyclic compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Oct 17, 2006·29 cites·28 claims
Showing the top 50 of 200 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lijun Sun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →